Cargando…
The need to accelerate access to new drugs for multidrug-resistant tuberculosis
Approximately half a million people are thought to develop multidrug-resistant tuberculosis annually. Barely 20% of these people currently receive recommended treatment and only about 10% are successfully treated. Poor access to treatment is probably driving the current epidemic, via ongoing transmi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Health Organization
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490806/ https://www.ncbi.nlm.nih.gov/pubmed/26170507 http://dx.doi.org/10.2471/BLT.14.138925 |